key: cord-0707946-7vgrk1kv authors: Meltzer, Andrew C.; Newton, Sophia; Lange, Joel; Hall, Nicole C.; Vargas, Nataly Montano; Huang, Yihe; Moran, Seamus; Ma, Yan title: A randomized control trial of a multiplex gastrointestinal PCR panel versus usual testing to assess antibiotics use for patients with infectious diarrhea in the emergency department date: 2022-01-15 journal: J Am Coll Emerg Physicians Open DOI: 10.1002/emp2.12616 sha: a2eaa9e62f70b7824e7c9fd9d93f1c9b7a0abcd0 doc_id: 707946 cord_uid: 7vgrk1kv OBJECTIVE: This study analyzed physician treating behavior through the use of a multiplex gastrointestinal polymerase chain reaction (GI PCR) test compared with usual testing in emergency department (ED) patients with suspected acute infectious diarrhea to assess differences in antibiotic management. METHODS: A prospective, single‐center, randomized control trial was designed to investigate antibiotic use in ED patients with moderate to severe suspected infectious diarrhea, comparing those who received GI PCR to those who received usual testing. ED patients with signs of dehydration, inflammation, or persistent symptoms were randomized to either the experimental arm (GI PCR) or the control arm (usual testing or no testing). RESULTS: A total of 74 patients met study criteria and were randomized to either the experimental GI PCR arm (n = 38) or to the control arm (n = 36). Participants in the GI PCR arm received antibiotics in 87% of bacterial or protozoal diarrheal infections (13/15) whereas those in the control arm received antibiotics in 46% of bacterial or protozoal infections (6/13) (P value 0.042) with 2‐proportion difference 0.41 (95% confidence interval 0.07 and 0.68). CONCLUSIONS: ED use of multiplex GI PCR led to an increase in antibiotic use for bacterial and protozoal causes of infectious diarrhea compared to usual testing. This increase in antibiotics appears to be appropriate given patients’ moderate to severe symptoms and a definitive identification of a likely bacterial or protozoal cause of symptoms. Results should be interpreted with caution because of the small sample size. Acute infectious diarrhea occurs commonly in the United States and leads to ≈500,000 hospitalizations and 5000 deaths annually. 1 There are many potential infectious etiologies including viral, bacterial, and protozoal classes but the causative microbe is usually not identified. 2 Traditional tests, such as stool cultures, have a low sensitivity and a long processing time and are not useful in the ED for real-time treatment decisions. In settings outside the ED, analysis of stool samples with polymerase chain reaction (PCR) tests have allowed for an increased detection of gastrointestinal (GI) pathogens and a decrease in inappropriate antibiotic use. ED clinicians must balance the well-established risk of overtreatment with unnecessary antibiotics in cases of viral diarrhea with the fact that appropriate antibiotic usage can reduce the duration and severity of symptoms and mitigate risk of future spread in cases of bacterial diarrhea. [3] [4] [5] Because of concerns about overtreatment of viral diarrhea, current guidelines do not recommend empiric antibiotic therapy for infectious diarrhea except for traveler's diarrhea or when a clinically plausible organism is identified. 6 With the introduction of multiplex GI PCRs, diarrheal sources can be identified in about an hour thus allowing testing and treatment during a single visit. It is unknown how the use of a multiplex PCR test changes ED management for patients with suspected acute infectious diarrhea. In this single-center randomized control study, we aimed to compare how appropriate antibiotic use differed for ED patients with acute infectious diarrhea who received a GI PCR test in the ED versus those that received usual diagnostic testing. The design of this study is a single-center randomized controlled trial. ED patients were screened for enrollment from November If a patient met study criteria and consented to enroll in the trial, they were randomized to either the experimental arm with the GI PCR or to the control arm with usual testing or no testing. Participants were randomized in a 1:1 ratio via the computerized randomization feature embedded within the REDCap data management software. Initially, randomization occurred after consent and eligibility was established. However, owing to the fact that many patients qualified for the study but were unable to provide a timely stool sample, we made an in-study modification to the protocol to change the time of randomization until after the stool sample was provided for patients who qualified. In the GI PCR arm, the collected stool was analyzed in a Clinical Lab- In the control arm, clinicians were asked not to order the GI PCR on initial stool sample but received no restrictions on other test ordering. For these patients, the stool sample was frozen in a negative 80-degree freezer to be analyzed at the conclusion of the study to ensure that both arms were balanced by type and class of pathogen. All other ED care was per physician discretion in both groups including the ordering of intravenous fluids, radiographic testing, antibiotic administration, medication prescription, and hospital admission. The primary outcome was administration of antibiotics for bacteria or protozoal diarrhea either in the ED or as a prescription at the time of discharge. Antibiotic use was generally considered appropri- Although patients were enrolled prospectively, the primary outcome was generally obtained via a chart review using a structured data sheet with trained abstractors per established methods. 11 At the point of enrollment, abstractors who were blinded to group assignment collected participant data from the EHR using a standardized data collec- ical factors were chosen to be included in the full logistic model: "How many episodes of diarrhea have you had?"+ "When did this episode of diarrhea start?"+ "Nausea" + "Vomiting"+ "Abdominal Pain" + "Fever" + "Blood in Stool"+ "Recent travel" + "Currently using any prescription antibiotics?" + "Triage Pulse (bpm)" + "Triage sbp" + "SpO2 (%)" There were 663 screenings that led to 87 (13%) randomizations and 74 participants who received study allocation (Figure 1 ). For many eligible patients, a stool sample was not provided. Baseline characteristics, microbes identified, and ED management are summarized by treatment group. A total of 74 patients provided diarrheal stool samples and were randomized to either the experimental GI PCR arm or to the control arm consisting of no testing or usual testing. There were no statistically significant differences between treatment groups in characteristics at baseline except for heart rate and systolic blood pressure (Table 1 ). Participants in the GI PCR arm received antibiotics in 87% of bacterial or protozoal diarrheal infections (13/15) whereas those in the control arm received antibiotics in 46% of bacterial or protozoal infections (6/13) (P value 0.042) ( Table 2 ). The 2-proportion difference was 0.41 with 95% CI of 0.07 and 0.68. The intensity of the ED work-up is evident in the high rates of intravenous rehydration therapy and computed tomography scans ( (Table 4 ). The findings of this study have to be seen in light of some limitations. In this single-center randomized control trial, ED patients with acute infectious diarrhea caused by bacteria or protozoa were more likely to be treated with antibiotics if they received a GI PCR test than those who received usual testing or no testing. A GI PCR testing strategy increased the rate of antibiotic prescriptions for a bacterial or protozoal infection by 40% compared to the usual practice control group. To our knowledge, this is the first randomized controlled trial on the topic in the ED setting but our findings are similar to prior studies in other settings. In the primary care setting, a GI PCR strategy showed an increased detection of GI pathogens when using compared to routine testing (28.3% vs 8.3%) for patients with presumed infectious diarrhea. 15 In an inpatient study of 699 patients with acute watery diarrhea, GI PCR led to a decrease in inappropriate antibiotic use from 42.9% to 25.8% compared to traditional diagnostic modalities. 16 Furthermore, the more rapid test results led to a reduced time in isolation for hospitalized patients and a reduced total number of antibiotic days. 17 In addition, a rapid diagnostic strategy led to 1-day reduction in time to initiation of targeted treatment versus empiric treatment in hospitalized patients with diarrhea (1 day vs 2 days) associated with use of rapid GI PCR panel. 18 Finally, patients with likely infectious diarrhea who were tested with the GI PCR were more likely to receive antibiotics for bacterial infection as part of a retrospective chart review. 19 Ideally, rapid testing panels increase a clinician's ability to identify treatable pathogens at the point of care and may improve treatment and infection control. 19, 20 One implication of this study is that it demonstrates that microbiological testing may be necessary for physicians to distinguish bacterial from viral causes of acute infectious diarrhea. Prior literature shows that neither bloody nor persistent diarrhea were associated with positive stool culture. 21 A logistic regression analysis performed as part of secondary outcomes for this study iden- Before the pandemic, the biggest challenge to enrollment was that eligible patients were often unable to provide a timely stool sample in the ED. We made the presumption that if a patient was unable to provide a stool sample after several hours in the ED, they most likely belonged to a more benign cohort and were more likely to represent a benign cohort. In the future, a rectal swab to collect samples might be a promising collection strategy if approved by FDA and manufacturer. A test-and-treat strategy for ED diarrhea could challenge current guidelines that recommend diarrheal testing only on the basis of history of travel and to withhold antibiotics for community acquired diarrhea owing to the likelihood of viral etiology such as norovirus, rotavirus, and adenovirus. 8 A test-and-treat strategy has been shown feasible with other ED GI complaints and could also be feasible with infectious diarrhea. 22 One potential criticism of using GI PCR in the ED is that testing will lead to overuse of antibiotics and patients with mild disease will be unnecessarily treated for a condition that is typ- This study illustrates how physicians must carefully balance the competing risks of overtreatment and undertreatment for a given condition. Antibiotic treatment confers a risk of adverse drug events such as acute hypersensitivity reaction, C. difficile infection, acute kidney injury, or cardiotoxicity. 23 One study even asserts that up to 19.3% of all ED visits for adverse drug reactions were due to antibioticassociated adverse events. 24 Future research should include a qualityimprovement style study comparing physician behavior and patient outcomes before and after the introduction of these PCR-based diagnostic tests. The ED setting draws patients for a variety of reasons including the desire to get a rapid diagnostic test that may not be available in other settings. Technology such as GI PCR that allows rapid identification of specific infection provides actionable information and minimizes the need for empiric treatment of disease. The public health implications of rapid microbiological testing are well known to physicians and the laypublic as a result of the COVID-19 pandemic. 25 Rapid testing may also be important for surveillance of GI diseases in community outbreaks and scenarios such as restaurants, schools, and cruise ships. In certain cases, rapid diagnosis may lead to earlier public health interventions. In summary, this randomized clinical trial showed that ED patients with moderately severe acute infectious diarrhea were more likely to receive antibiotics for treatment of bacterial diarrhea if they were tested with a multiplex PCR test than if they received usual diagnostic testing. Although the study was limited by early termination, it shows how early detection changes physician management. If a clinical benefit of antibiotic antidiarrheal therapy for bacterial infectious diarrhea is established, testing with GI PCR challenges current guidelines that recommend antibiotic antidiarrheal treatment only on the basis of history of travel. Future studies will need to address how GI PCR affects overall cost, risks of antibiotic side effects, and risks of antibiotic overuse and resistance. None. Andrew C. Meltzer conceived the study, designed the trial, and The rate of acute gastrointestinal illness in developed countries Foodborne illness acquired in the united states-major pathogens Practice guidelines for the management of infectious diarrhea Empirical treatment of severe acute community-acquired gastroenteritis with ciproftoxacin Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults 2017 infectious diseases society of america clinical practice guidelines for the diagnosis and management of infectious diarrhea Multicenter evaluation of the biofire filmarray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with escherichia coli O157: h7 infection? Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies Statistical Methods for Rates and Proportions. Third Edition Two-sided confidence intervals for the single proportion: comparison of seven methods Multiplex polymerase chain reaction test to diagnose infectious diarrhea in the emergency department Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens Rapid molecular detection of gastrointestinal pathogens and its role in antimicrobial stewardship Impact of the biofire filmarray gastrointestinal panel on patient care and infection control Use of biofire filmarray gastrointestinal PCR panel associated with reductions in antibiotic use, time to optimal antibiotics, and length of stay Multiplex polymerase chain reaction test to diagnose infectious diarrhea in the emergency department Multiplex gastrointestinal pathogen panels: implications for infection control Predictors of positive stool culture in adult patients with acute infectious diarrhea Treating gastritis, peptic ulcer disease, and *-dyspepsia in the emergency department: the feasibility and patient-reported outcomes of testing and treating for helicobacter pylori infection Association of adverse events with antibiotic use in hospitalized patients Emergency department visits for antibiotic-associated adverse events Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19 Andrew C. Meltzer